Genomic Risk for Retroperitoneal Liposarcoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores why tumors often return in patients with retroperitoneal liposarcoma, a type of cancer in the abdomen. Researchers aim to determine if normal-looking abdominal fat contains hidden genetic changes that cause cancer recurrence. During tumor removal surgery, participants will provide samples of their abdominal fat for analysis. Eligible participants have been diagnosed with retroperitoneal liposarcoma and are planning surgery for its removal. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future cancer treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on the genomic risk in retroperitoneal sarcoma, particularly retroperitoneal liposarcoma. Unlike traditional treatments like surgery, chemotherapy, or radiation, which aim to physically remove or destroy the tumor, this trial investigates the genetic factors that could influence the development and recurrence of the cancer. By understanding these genomic risks, there is potential to personalize treatment strategies, improve surgical outcomes, and reduce recurrence rates. This approach represents a shift towards more tailored and effective treatment plans for patients with retroperitoneal sarcoma.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Resection
Participants undergo surgical resection of their retroperitoneal liposarcoma tumor
Genetic Analysis
Retroperitoneal fat is sampled and subjected to genetic analyses to identify predisposing factors for liposarcoma
Follow-up
Participants are monitored for recurrence and genetic changes in retroperitoneal fat
What Are the Treatments Tested in This Trial?
Interventions
- Biospecimen sample collection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fox Chase Cancer Center
Lead Sponsor